Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription Articles published in Am J Surg Retrieve available abstracts of 37 articles: HTML format

Single Articles

November 2025
1. FUNG MHM, Ng WI, Lee HE, Chan TH, et al
   The role of artificial intelligence in surgeon-performed ultrasonographic evaluation of cytologically indeterminate thyroid nodules.
   Am J Surg. 2025;249:116599.
   PubMed     Abstract available
   
   
   October 2025
2. PATEL H, Somasundar P, Espat NJ, Calvino AS, et al
   Defining the role of thyroidectomy in patients with metastatic differentiated thyroid carcinoma by age groups.
   Am J Surg. 2025;250:116660.
   PubMed     Abstract available
   
   
   
3. ZHANG G, Chen Y, Jin D, Sui Z, et al
   Postoperative survival evaluation of patients with Siewert II adenocarcinoma of esophagogastric junction: a population-based study.
   Am J Surg. 2025;248:116536.
   PubMed     Abstract available
   
   
   
4. DONE JZ, Helbing A, Stemme R, Foote D, et al
   Higher Distressed Communities Index is associated with more aggressive features in papillary thyroid cancer.
   Am J Surg. 2025;248:116520.
   PubMed     Abstract available
   
   
   
5. MONREAL AJ, Eze AN, Thomas SM, Johnson KS, et al
   Exploring actionable targets to address disparities in thyroid cancer survival: A study of patients with aggressive variants of papillary thyroid cancer.
   Am J Surg. 2025;248:116428.
   PubMed     Abstract available
   
   
   
6. LAURIE BD, Thomas E, Nguyen H, Ryan S, et al
   FDG-avid thyroid nodules are at a significantly increased risk of malignancy.
   Am J Surg. 2025;248:116400.
   PubMed     Abstract available
   
   
   September 2025
7. FINNERTY BM, Marshall T, Annesi CA, Zarnegar R, et al
   Thyroid-stimulating immunoglobulin is not associated with aggressive clinicopathologic features in concomitant Graves' disease and papillary thyroid cancer.
   Am J Surg. 2025;247:116487.
   PubMed     Abstract available
   
   
   
8. AKINYEMI O, Weldeslase T, Fasokun M, Eze O, et al
   Medicaid expansion and thyroid cancer stage at presentation: A comparative study of two US states.
   Am J Surg. 2025;247:116447.
   PubMed     Abstract available
   
   
   August 2025
9. DING Y, Feng Z, Cao K
   Total thyroidectomy does not improve survival for all patients with unilateral papillary thyroid cancer exceeding 4 ?cm.
   Am J Surg. 2025;246:116395.
   PubMed     Abstract available
   
   
   May 2025
10. AMERI K, Kwon M, Watanabe A, Wiseman SM, et al
    Thyroid cancer quality of care indicators: A scoping review.
    Am J Surg. 2025;243:116223.
    PubMed     Abstract available
    
    
    March 2025
11. RAMESH S, Fisher JC, Curcio P, Rothberger GD, et al
    Malignancy risk associated with radioactive iodine therapy for Graves' disease.
    Am J Surg. 2025;241:116075.
    PubMed     Abstract available
    
    
    
12. RYU YJ, Hsu SY, Kuo EJ, Liou R, et al
    Radiofrequency ablation of Bethesda category III thyroid nodules with benign molecular testing: Preliminary findings from a single institution.
    Am J Surg. 2025;241:115929.
    PubMed     Abstract available
    
    
    February 2025
13. ZMIJEWSKI P, Nwaiwu C, Nakanishi H, Farsi S, et al
    Racial disparities in thyroid cancer outcomes: A systematic review.
    Am J Surg. 2025;240:115991.
    PubMed     Abstract available
    
    
    January 2025
14. BARRIO MJ, Pozdeyev N, McIntyre RC Jr, Albuja-Cruz MB, et al
    Long term outcomes after repeat lymph node dissections for persistent or recurrent differentiated thyroid cancer.
    Am J Surg. 2025;239:116045.
    PubMed     Abstract available
    
    
    December 2024
15. MARSHALL TE, Ibrahim R, Lee-Saxton YJ, Tumati A, et al
    Disparities in postoperative adjuvant therapy utilization and factors impacting survival among anaplastic thyroid cancer patients.
    Am J Surg. 2024;238:115944.
    PubMed     Abstract available
    
    
    
16. COGUA LM, Tupper CJ, Silberstein PT, Coan KE, et al
    Intermediate-sized follicular thyroid cancer surgical trends before and after the 2015 American thyroid association guideline changes.
    Am J Surg. 2024;238:115830.
    PubMed     Abstract available
    
    
    
17. BARRIO MJ, Pozdeyev N, Raeburn CD, McIntyre RC Jr, et al
    Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy.
    Am J Surg. 2024;238:115818.
    PubMed     Abstract available
    
    
    November 2024
18. CHAN SJ, Betcher MC, Kuo EJ, McManus CM, et al
    Trends in thyroid function following radiofrequency ablation of benign, nonfunctioning thyroid nodules: A single institution review.
    Am J Surg. 2024;237:115793.
    PubMed     Abstract available
    
    
    October 2024
19. ROSSI L, De Palma A, Ambrosini CE, Fregoli L, et al
    Histologic parameters driving completion thyroidectomy for papillary thyroid carcinoma in a high-volume institution: A retrospective observational study.
    Am J Surg. 2024;239:116016.
    PubMed     Abstract available
    
    
    August 2024
20. SU MW, Beck TN, Knepprath J, Romero-Velez G, et al
    Primary thyroid lymphoma: A multi-center retrospective review.
    Am J Surg. 2024;237:115927.
    PubMed     Abstract available
    
    
    
21. MONREAL A, Eze AN, Kazaure HS
    Presentation and management of medullary thyroid cancer by sex and race/ethnicity in the United States-A state of disunion.
    Am J Surg. 2024;234:17-18.
    PubMed    
    
    
    
22. GILLIS A, Zmijewski P, Mcleod MC, Lindeman B, et al
    Racial implications of time to surgery in disparities in thyroid cancer survival.
    Am J Surg. 2024;234:85-91.
    PubMed     Abstract available
    
    
    
23. KALVA S, Ginzberg SP, Passman JE, Soegaard Ballester JM, et al
    Sex differences and racial/ethnic disparities in the presentation and treatment of medullary thyroid cancer.
    Am J Surg. 2024;234:19-25.
    PubMed     Abstract available
    
    
    July 2024
24. BROEKHUIS JM, Gartland RM
    More than meets the size: Evaluating guideline impact on extent of surgery for follicular thyroid carcinoma.
    Am J Surg. 2024 Jul 26:115863. doi: 10.1016/j.amjsurg.2024.115863.
    PubMed    
    
    
    
25. ABRAHAM PJ, Wu C, Wang R, Herring B, et al
    The overtreatment of papillary thyroid microcarcinoma in the community.
    Am J Surg. 2024;233:132-135.
    PubMed     Abstract available
    
    
    
26. BECK TN, Romero-Velez G, Noureldine SI, Plitt G, et al
    Bilateral exploration in primary hyperparathyroidism: Double adenoma distribution and biochemical patterns over two decades.
    Am J Surg. 2024;233:61-64.
    PubMed     Abstract available
    
    
    June 2024
27. LI R, Luo Q, Gutierrez ID
    Asian Americans have higher 30-day surgical complications after esophagectomy: A propensity-score matched study from ACS-NSQIP database.
    Am J Surg. 2024;232:75-80.
    PubMed     Abstract available
    
    
    April 2024
28. NABATA KJ, Lim R, Leong R, Wiseman SM, et al
    To infinity and beyond: A historical bibliometric analysis of medullary thyroid carcinoma.
    Am J Surg. 2024 Apr 15:S0002-9610(24)00199-5. doi: 10.1016/j.amjsurg.2024.
    PubMed     Abstract available
    
    
    March 2024
29. LEONG D, Leslie C, Laurie B, Hou L, et al
    Tumour size predicts risk of recurrence in tall cell subtype papillary thyroid carcinoma.
    Am J Surg. 2024 Mar 26:S0002-9610(24)00184-3. doi: 10.1016/j.amjsurg.2024.
    PubMed     Abstract available
    
    
    
30. INNES AM, van Galen P
    Insights from the hereditary endocrine clinic.
    Am J Surg. 2024;229:203-204.
    PubMed    
    
    
    
31. HERRERA M, Hussein MH, Persons E, Alias MR, et al
    Survival benefits of extensive surgery in patients with papillary thyroid microcarcinoma.
    Am J Surg. 2024;229:99-105.
    PubMed     Abstract available
    
    
    
32. TRAN A, Weigel RJ, Beck AC
    ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence.
    Am J Surg. 2024;229:106-110.
    PubMed     Abstract available
    
    
    February 2024
33. SMITH ER, Frye CC, Pandian TK, Gillanders WE, et al
    Molecular characteristics of isthmus papillary thyroid cancers: Supporting evidence for unfavorable clinical behavior.
    Am J Surg. 2024;228:146-150.
    PubMed     Abstract available
    
    
    
34. MONTGOMERY KB, Fazendin JM, Chen H, Broman KK, et al
    Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.
    Am J Surg. 2024;228:173-179.
    PubMed     Abstract available
    
    
    August 2023
35. KUO LE, Suh I
    Can we improve preoperative staging for thyroid cancer?
    Am J Surg. 2023;226:170.
    PubMed    
    
    
    
36. K SAH R, Mayilvaganan S
    "Primary hyperparathyroidism after radioactive iodine therapy. Is it a distinct clinical entity?".
    Am J Surg. 2023;226:296.
    PubMed    
    
    
    
37. SOEGAARD BALLESTER JM, Finn CB, Ginzberg SP, Kelz RR, et al
    Thyroid cancer pathologic upstaging: Frequency and related factors.
    Am J Surg. 2023;226:171-175.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.